Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromycin for prokinesis: imprudent prescribing?

Martino Dall'Antonia1, Mark Wilks, Pietro G Coen

  • 1Queen Elizabeth Hospital NHS Trust, Stadium Road, Woolwich, London SE18 4QH, UK. mdallantonia@nhs.net

Critical Care (London, England)
|January 20, 2006
PubMed
Summary

Using erythromycin for gastrointestinal motility in intensive care units (ICUs) is concerning. This practice may increase antibiotic resistance and Clostridium difficile infections, urging the use of alternative prokinetic agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood culture pathways in UK hospitals: an exploratory survey.

The Journal of hospital infection·2026
Same author

Bacterial DNA detection in blood using PCR/ESI-MS in neonates with suspected early onset infection.

Frontiers in cellular and infection microbiology·2025
Same author

Exploring the Link Between Obligate Anaerobe-Related Dysbiosis and Prostate Cancer Development: A Pilot Study.

Cancers·2025
Same author

Publisher Correction: Unified metagenomic method for rapid detection of microorganisms in clinical samples.

Communications medicine·2024
Same author

Unified metagenomic method for rapid detection of microorganisms in clinical samples.

Communications medicine·2024
Same author

Impact of penicillin allergy records on antimicrobial prescribing in hospitalised patients.

Clinical medicine (London, England)·2024

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pharmacology

Background:

  • Antibiotic-resistant bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter baumanii, and extended-spectrum beta-lactamase (ESBL) producing gram-negative bacilli, pose significant challenges in hospital settings, especially in intensive care units (ICUs).
  • Early enteral feeding is associated with improved survival rates in ICU patients.
  • Prokinetic agents are commonly administered to manage gastrointestinal dysmotility in critically ill patients.

Purpose of the Study:

  • To evaluate the implications of using sub-therapeutic doses of erythromycin as a prokinetic agent in ICU patients.
  • To highlight the potential risks associated with this practice, specifically concerning the development and spread of antibiotic resistance and Clostridium difficile infections.

Main Methods:

Related Experiment Videos

  • This study is a review and critical analysis of current clinical practices regarding the use of erythromycin as a prokinetic agent in ICUs.
  • Literature review on the impact of sub-therapeutic antibiotic use on antimicrobial resistance and C. difficile infections.

Main Results:

  • The use of erythromycin at sub-therapeutic doses as a prokinetic agent is linked to an increased emergence and spread of antibiotic resistance.
  • This practice also elevates the risk of Clostridium difficile-associated diseases.
  • The administration of antibiotics for non-antimicrobial purposes, such as prokinetic effects, is not considered prudent antimicrobial prescribing.

Conclusions:

  • The use of erythromycin as a prokinetic agent in ICUs is strongly discouraged due to the significant risks of promoting antibiotic resistance and C. difficile infections.
  • Alternative prokinetic agents should be prioritized whenever feasible to ensure appropriate antimicrobial stewardship.
  • Avoiding the off-label use of antibiotics for non-antimicrobial indications is crucial for infection control and patient safety in critical care settings.